Jennison Associates
AZN icon

Jennison Associates’s AstraZeneca AZN Stock Holding History

Jennison Associates’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-557,500
Closed -$38M – 652
2017
Q2 		$38M Buy
557,500
+207,500
+59% +$13.6M 0.04% 309
2017
Q1 		$21.8M Buy
+350,000
New +$20.4M 0.02% 410

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates's AZN Position: Q2 2026 in Review

Jennison Associates increased its AstraZeneca (AZN) stake by 0.38% in Q2 2026, buying an estimated $480K and bringing the position to 666,497 shares worth $126M. The position accounts for 0.08% of the portfolio, ranked #127.

Jennison Associates first reported a position in AZN in Q1 2014 and has held it in 45 quarters since. The position peaked at $2.07B in Q2 2020. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Jennison Associates held 666,497 shares of AstraZeneca worth $126M as of Q2 2026.
  • Jennison Associates bought 2,552 AstraZeneca shares in Q2 2026, an estimated $480K.
  • AstraZeneca made up 0.08% of Jennison Associates's portfolio in Q2 2026, its #127 holding.
  • Jennison Associates first reported a position in AstraZeneca in Q1 2014 and has held it in 45 quarters since.
  • Jennison Associates's AstraZeneca position peaked at $2.07B in Q2 2020.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.